Inclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen

Size: px
Start display at page:

Download "Inclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen"

Transcription

1 Inclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen Institute for Cancer Research, Norwegian Radium Hospital, University of Oslo

2 Theragnostics biological conformality Tumors are often spatially and temporally heterogeneous uniform tumor dose vs non-uniform tumor dose? Treatment optimization guided by biological images of the tumor

3 Theragnostics biological conformality The hypothesis is that non-invasive biological imaging may provide the pertinent information to guide the painting or sculpting of the optimal dose distribution. C.C. Ling, Int. J. Radiat. Oncol. Biol. Phys. 47: , 2000.

4 Theragnostics biological conformality Sir William Osler: The principles and practice of Medicine, 1892 If it were not for the great variability among individuals, medicine might as well be a science and not an art

5 Theragnostics Challenge 1: How to obtain relevant and valid biological information applicable to treatment plan optimization?

6 Theragnostics

7 Theragnostics A): Metabolism (FDG) B): proliferation (FLT) C): hypoxia (Cu-ATSM) D): angiogenesis (MMP) Apisarnthanaraxa & Chao, RADIATION RESEARCH 163, 1 25, 2005.

8 Theragnostics Molecular markers and tracers in PET Mechanism of FDG in functional imaging D. Heron, et al. Medical Dosimetry, 31(1):3-11, 2005.

9 Theragnostics Dynamic contrast enhances MRI: Perfusion, oxygenation Diffusion MRI: Cellular integrity, cell death MRSi: metabolism dce-mri

10 dce- MRI & tumor hypoxia Frequency (%) po 2 (mm Hg) probe MR C i ( t ) = K t Ki ( t u ) trans ν e, i i Ca( u )e 0 trans du E PERF K (ml / (g min) ) trans po 2 (mm Hg)

11 dce- MRI & tumor hypoxia po 2, calc 1: > 20 mm Hg 2: 5-20 mm Hg 3: mm Hg Compartmentization 4: < 0.5 mm Hg

12 Optimization Challenge 2: How to utilize the information in dose distribution optimization? Image of a relevant biological parameters Ideal dose map Planned dose map

13 Optimization Dose modifying factor: D i =OER i (p i ) * D ox

14 Optimization Constraint: - maintaining the mean dose to the target volume: - iso-biological effect in each voxel of the target volume: TCP = TCP [ V, ρ, α(oer),β(oer), γ ] volume density radiosensitivity repopulation rate

15 Optimization where f i (d) is the normalized dose distribution for compartment i, and the integration over N i (d)f i (d) yields the expected number of surviving clonogens in the given compartment. The total TCP is given by the product of the probabilities for controlling each compartment and is obtained by integrating the product over a distribution of radiation sensitivities g(α O ):

16 Optimization For a tumour with a non-uniform distribution of radiation sensitivity, the optimal dose distribution for a given mean dose is the distribution which gives a uniform density ρ of surviving clonogens in the tumour:

17 Optimization

18 Optimization Prescribed compartmental doses and calculated TCP for a uniform and nonuniform prescription scheme.

19 Optimization TCP for a non-uniform and a uniform dose distribution of equal mean dose for four cases. TCP for varying numbers of dose prescription compartments for cases 2 and 3.

20 Optimization

21 Dynamics Challenge 3: How to deal with and systematic and random errors, and spatial and temporal changes? Treatment fraction K trans

22 Dynamics A B Systematic and random errors: The effect on the TCP by randomly (A) or systematically (B) assigning voxels to other tumour compartments.

23 Dynamics Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5 Fraction 7 Fraction 9 Fraction 10 Spatial distribution of po 2 segmented into four compartments, on 16 of the 18 treatment fractions. Fraction 11 Fraction 12 2 Fraction 13 Fraction Fraction 15 Fraction 16 Fraction 17 Fraction 18

24 Dynamics Hypoxic volume fractions (A) and corresponding optimal dose per treatment fraction (B) for different compartments for each of the treatment fractions.

25 Dynamics 40% reoxygenation TCP as a function of dose per fraction to the normoxic compartment for: no reoxygenation ( ) 10% reoxygenation ( ) 20% reoxygenation( ) 30% reoxygenation( ) 40% reoxygenation ( ) no reoxygenation The dose per fraction to the normoxic compartment was kept constant.

26 Dynamics uniforme dose TCP drops with increasing fraction of acute hypoxic cells, and is lowest appying a uniform dose as compared to non-uinform dose. TCP increases with increasing fraction of the chronic hypoxic celles that receive the intended dose

27 Dynamics

28 Multi-parametric optimization Challenge 4: How to deal with multiple parameters/ information?

29 The Pareto principle: for many events, 80% of the effects come from 20% of the causes. Does this apply to radiation oncology optimization? Can we identify the critical 20% component? Wilfried Fritz Pareto

30 Thank you for your attention!

The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning.

The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning. The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning. KAROLINA KOKUREWICZ S U P E R V I S O R S : D I N O J A R O S Z Y N S K I, G I U S E P P E S C

More information

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent

More information

Moving Beyond RECIST

Moving Beyond RECIST Moving Beyond RECIST Ihab R. Kamel, M.D., Ph.D. [email protected] Associate Professor Clinical Director, MRI Department of Radiology The Johns Hopkins University School of Medicine Outline Standard measures

More information

Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer

Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer A/Prof Celi Varol and Dr Orit Raz Uro-Oncologist Nepean and Macquarie Hospital Trial at Macquarie University Hospital Ethics board

More information

Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT

Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT Daily IGRT with CT-on-Rails Can Safely Reduce Planning Margin for Prostate Cancer: Implication for SBRT Wen Li, Andrew Vassil, Lama Mossolly, Qingyang Shang, Ping Xia Department of Radiation Oncology Why

More information

DWI Case Study - QIBA PDF- MRI Technical Committee. What is IMI?

DWI Case Study - QIBA PDF- MRI Technical Committee. What is IMI? DWI Case Study - QIBA PDF- MRI Technical Committee QIBA Annual Meeting May 21, 2014 What is IMI? The Innovative Medicines Initiative (IMI) is the world s largest biomedical /healthcare public-private initiative

More information

THE DOSIMETRIC EFFECTS OF

THE DOSIMETRIC EFFECTS OF THE DOSIMETRIC EFFECTS OF OPTIMIZATION TECHNIQUES IN IMRT/IGRT PLANNING 1 Multiple PTV Head and Neck Treatment Planning, Contouring, Data, Tips, Optimization Techniques, and algorithms AAMD 2013, San Antonio,

More information

Current and Future Trends in Proton Treatment of Prostate Cancer

Current and Future Trends in Proton Treatment of Prostate Cancer Current and Future Trends in Proton Treatment of Prostate Cancer Reinhard W. Schulte Assistant Professor Department of Radiation Medicine Loma Linda University Medical Center Loma Linda, CA, USA Outline

More information

QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET

QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET Centers for Quantitative Imaging Excellence (CQIE) LEARNING MODULE QUANTITATIVE IMAGING IN MULTICENTER CLINICAL TRIALS: PET American College of Radiology Clinical Research Center v.1 Centers for Quantitative

More information

Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012

Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012 Radiation Oncology Nursing Care Helen Lusby Radiation Oncology Nurse BAROC 2012 Definitions Radiation Therapy: Treatment of cancer using x- ray particles that cause ionisation within the cells. External

More information

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward 33 rd Annual Internal Medicine Update December 5, 2015 Ryan C. Hedgepeth, MD, MS Chief of

More information

Robert Bristow MD PhD FRCPC

Robert Bristow MD PhD FRCPC Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research

More information

Qualitative Dosimetric and Radiobiological Evaluation of High Dose Rate Interstitial brachytherapy Implants

Qualitative Dosimetric and Radiobiological Evaluation of High Dose Rate Interstitial brachytherapy Implants Int. J. Med. Sci. 2008, 5 41 Research Paper International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2008 5(1):41-49 Ivyspring International Publisher. All rights reserved Qualitative Dosimetric

More information

CYBERKNIFE RADIOSURGERY FOR EARLY PROSTATE CANCER Rationale and Results. Alan Katz MD JD Flushing, NY USA

CYBERKNIFE RADIOSURGERY FOR EARLY PROSTATE CANCER Rationale and Results. Alan Katz MD JD Flushing, NY USA CYBERKNIFE RADIOSURGERY FOR EARLY PROSTATE CANCER Rationale and Results Alan Katz MD JD Flushing, NY USA Prostate Ablative Therapy Over the last 10 years our therapy has improved bned rates for LDR/HDR

More information

Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014.

Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014. Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience Richard Pötter MD BrachyNext, Miami, 2014 Disclosures Richard Pötter, MD, does not have any financial relationships or

More information

HERC Coverage Guidance Advanced Imaging for Staging of Prostate Cancer Disposition of Public Comments

HERC Coverage Guidance Advanced Imaging for Staging of Prostate Cancer Disposition of Public Comments Table of Contents Commenters... 1 Public Comments... 2 References Provided by Commenters... 6 Commenters Identification Stakeholder A Medical Imaging & Technology Alliance (MITA), Arlington, VA [Submitted

More information

Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate

Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_prostate

More information

TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software.

TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software. SAMPLE CLINICAL RESEARCH APPLICATION ABSTRACT: TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software. Hypothesis:

More information

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D. Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D., FACS Learning Objectives After reading and reviewing this

More information

Comparison of Threshold-Based Segmentation Methods on Pre- and Post- Therapy PET Scans

Comparison of Threshold-Based Segmentation Methods on Pre- and Post- Therapy PET Scans M. Phillips, S.F. Barrington, D.L.G. Hill, P.K. Marsden 1 Comparison of Threshold-Based Segmentation Methods on Pre- and Post- Therapy PET Scans Michael Phillips 1 [email protected] Sally F.

More information

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Christopher Martel, M.Sc., CHP Lisa Thornhill,, NRRPT, RT(NM) Boston University Medical Center Thyroid Carcinoma New cases and deaths in

More information

Brain Tumor Treatment

Brain Tumor Treatment Scan for mobile link. Brain Tumor Treatment Brain Tumors Overview A brain tumor is a group of abnormal cells that grows in or around the brain. Tumors can directly destroy healthy brain cells. They can

More information

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Cancer Cells Cancer, the 1st leading cause of death, is an example of a disease that arises from abnormalities in cell function

More information

In room Magnetic Resonance Imaging guided Radiotherapy (MRIgRT( MRIgRT) Jan Lagendijk and Bas Raaymakers

In room Magnetic Resonance Imaging guided Radiotherapy (MRIgRT( MRIgRT) Jan Lagendijk and Bas Raaymakers In room Magnetic Resonance Imaging guided Radiotherapy (MRIgRT( MRIgRT) Jan Lagendijk and Bas Raaymakers : Chris Bakker Boxue Liu Alexander Raaijmakers Rajko Topolnjak Richard van de Put Uulke van der

More information

Radiotherapy in locally advanced & metastatic NSC lung cancer

Radiotherapy in locally advanced & metastatic NSC lung cancer Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital. Locally advanced

More information

Immuno-Oncology Model Application in the Preclinical Treatment Setting

Immuno-Oncology Model Application in the Preclinical Treatment Setting Immuno-Oncology Model Application in the Preclinical Treatment Setting Maryland Franklin, Ph.D. Senior Director, Scientific Development [email protected] July 22, 2015 Tumor Models Conference

More information

Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation

Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs Michael Alvarado, MD Associate Professor of Surgery University of California San Francisco Case Study 59 yo woman with new palpable

More information

$ $; #! $ $ $ $. $ $, $ $,! $ # $ -$.! #,! # #. ' () «-,» ( ),. 2-3!!!, - $# (RF) #! $., - #! $ $, #. - & # $!.

$ $; #! $ $ $ $. $ $, $ $,! $ # $ -$.! #,! # #. ' () «-,» ( ),. 2-3!!!, - $# (RF) #! $., - #! $ $, #. - & # $!. & :!!" $%&', 15701 ' 7274548, fax: 7274742 e-mail: lmargar@bioluoagr http://kyttarikibioluoagr () %& *&!+ $ ',-" () (),, ( 310 11 Hz ),,!!! ", $! " (! 810 14 Hz! $,,, %, ), & &, ( ), $,!!!! $ $ &, ( mcurie),!!

More information

Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.

Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment. Dictionary Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment. Applicator A device used to hold a radioactive source

More information

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3

More information

A new score predicting the survival of patients with spinal cord compression from myeloma

A new score predicting the survival of patients with spinal cord compression from myeloma A new score predicting the survival of patients with spinal cord compression from myeloma (1) Sarah Douglas, Department of Radiation Oncology, University of Lubeck, Germany; [email protected] (2) Steven

More information

Monitoring Patient Radiation Dose in VA. Charles M. Anderson MD, PhD Chief Consultant for Diagnostic Services Veterans Health Administration

Monitoring Patient Radiation Dose in VA. Charles M. Anderson MD, PhD Chief Consultant for Diagnostic Services Veterans Health Administration Monitoring Patient Radiation Dose in VA Charles M. Anderson MD, PhD Chief Consultant for Diagnostic Services Veterans Health Administration TWENTY ONE/NOVEMBER 2011 Computed Tomography (CT), Magnetic Resonance

More information

MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION

MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION Nadia Terranova UNIVERSITÀ DI PAVIA New model development: course of action

More information

FACULTY OF ALLIED HEALTH SCIENCES

FACULTY OF ALLIED HEALTH SCIENCES FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes

More information

Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies

Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies John F. Ward, MD Assistant Professor University of Texas M. D. Anderson Cancer Center Ablation

More information

Proton Therapy for Prostate Cancer

Proton Therapy for Prostate Cancer Proton Therapy for Prostate Cancer Andrew K. Lee, MD, MPH Director, Proton Therapy Center Associate Professor Department of Radiation Oncology M.D. Anderson Cancer Center Randomized studies showing benefit

More information

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards

More information

Medical Applications of radiation physics. Riccardo Faccini Universita di Roma La Sapienza

Medical Applications of radiation physics. Riccardo Faccini Universita di Roma La Sapienza Medical Applications of radiation physics Riccardo Faccini Universita di Roma La Sapienza Outlook Introduction to radiation which one? how does it interact with matter? how is it generated? Diagnostics

More information

P4 Distribution of Cetuximab in Models of Human Lung Cancer

P4 Distribution of Cetuximab in Models of Human Lung Cancer Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, Robert Bosch Foundation Stuttgart, Germany FORSYS Partner Project Predictive Cancer Therapy Project Meeting 14.10.09

More information

Focal therapy for prostate cancer: seriously or seriously? Disclosures

Focal therapy for prostate cancer: seriously or seriously? Disclosures Focal therapy for prostate cancer: seriously or seriously? Mitchell Kamrava, MD Assistant Clinical Professor Department of Radiation Oncology University of California Los Angeles Disclosures Speaking honorarium

More information

Frequency of NHL Subtypes in Adults

Frequency of NHL Subtypes in Adults Chemotherapy Options Stephanie A. Gregory, M.D. The Elodia Kehm Professor of Medicine Director, Section of Hematology Rush University Medical Center Chicago, Illinois Frequency of NHL Subtypes in Adults

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

Ventilation Perfusion Relationships

Ventilation Perfusion Relationships Ventilation Perfusion Relationships VENTILATION PERFUSION RATIO Ideally, each alveolus in the lungs would receive the same amount of ventilation and pulmonary capillary blood flow (perfusion). In reality,

More information

Medical Physics and Radioactivity

Medical Physics and Radioactivity Medical Physics and Radioactivity Radioactivity Unstable nucleus Electromagnetic wave particle Atoms which emit electromagnetic radiation or a particle by the spontaneous transformation of their nucleus

More information

Future Directions in Cancer Research What does is mean for medical physicists and AAPM?

Future Directions in Cancer Research What does is mean for medical physicists and AAPM? Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman

More information

HER2 Status: What is the Difference Between Breast and Gastric Cancer?

HER2 Status: What is the Difference Between Breast and Gastric Cancer? Ask the Experts HER2 Status: What is the Difference Between Breast and Gastric Cancer? Bharat Jasani MBChB, PhD, FRCPath Marco Novelli MBChB, PhD, FRCPath Josef Rüschoff, MD Robert Y. Osamura, MD, FIAC

More information

Introduction to the Monte Carlo method

Introduction to the Monte Carlo method Some history Simple applications Radiation transport modelling Flux and Dose calculations Variance reduction Easy Monte Carlo Pioneers of the Monte Carlo Simulation Method: Stanisław Ulam (1909 1984) Stanislaw

More information

Disclosures for Elena Zamagni

Disclosures for Elena Zamagni Prognostic relevance of 18F-FDG PET/CT in newly diagnosed multiple myeloma patients receiving upfront autologous stem-cell transplantation: a prospective study Zamagni E. 1, Nanni C. 2, Patriarca F. 3,

More information

[Image removed due to copyright concerns]

[Image removed due to copyright concerns] Radiation Chemistry Ionizing radiation produces abundant secondary electrons that rapidly slow down (thermalize) to energies below 7.4 ev, the threshold to produce electronic transitions in liquid water.

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection

PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection PET-CT Can we afford PET-CT John Buscombe New technology Combines functional information-pet anatomical information-ct Machine able to perform both studies in single imaging episode PET imaging depends

More information

REVIEW OF EXPOSURE LIMITS AND HEALTH CONCERNS SANTA ANA. Base Station Telecommunication Transmitters UNIFIED SCHOOL DISTRICT

REVIEW OF EXPOSURE LIMITS AND HEALTH CONCERNS SANTA ANA. Base Station Telecommunication Transmitters UNIFIED SCHOOL DISTRICT SANTA ANA UNIFIED SCHOOL DISTRICT REVIEW OF EXPOSURE LIMITS AND HEALTH CONCERNS Base Station Telecommunication Transmitters Dr. Karl Rodenbaugh, Senior Scientist SCOPE OF SERVICES Review, Describe, Discuss,

More information

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.

More information

BEYOND 18 F-FDG: INTRODUCTION TO NEW RADIOPHARMACEUTICALS

BEYOND 18 F-FDG: INTRODUCTION TO NEW RADIOPHARMACEUTICALS BEYOND F-FDG: INTRODUCTION TO NEW RADIOPHARMACEUTICALS Asti Mattia Nuclear Medicine Department Santa Maria Nuova Hospital, Reggio Emilia, Italy SUMMARY: F-Labelled Choline analogues. Comparison between

More information

PET/CT-MRI First clinical experience

PET/CT-MRI First clinical experience 20 th April 2013, Barcelona, Sp PET/CT-MRI First clinical experience Philippe Appenzeller, MD Staff Radiologist and Nuclear Medicine Physician Department Medical Imaging, University Hospital Zurich PET/CT-MR

More information

Failure Modes and Effects Analysis (FMEA)

Failure Modes and Effects Analysis (FMEA) Failure Modes and Effects Analysis (FMEA) Sasa Mutic Washington University School of Medicine St. Louis Missouri Failure Modes and Effects Analysis Objectives: To motivate the use of FMEA and to provide

More information

Guidelines for pharmacokinetic and pharmacodynamic studies in early phase clinical trials

Guidelines for pharmacokinetic and pharmacodynamic studies in early phase clinical trials Guidelines for pharmacokinetic and pharmacodynamic studies in early phase clinical trials Introduction The Pharmacodynamic/ pharmacokinetic Technologies Advisory Committee (PTAC) of Cancer Research UK

More information

Analysis of Set-up Errors during CT-scan, Simulation, and Treatment Process in Breast Cancer Patients

Analysis of Set-up Errors during CT-scan, Simulation, and Treatment Process in Breast Cancer Patients 대한방사선종양학회지 2005;23(3):169~175 Analysis of Set-up Errors during CT-scan, Simulation, and Treatment Process in Breast Cancer Patients Department of Radiation Oncology, College of Medicine, Ewha Womans University

More information

Modelling the spread of brain tumours

Modelling the spread of brain tumours Snapshots of modern mathematics from Oberwolfach 13/2015 Modelling the spread of brain tumours Amanda Swan Alber t Mur tha The study of mathematical biology attempts to use mathematical models to draw

More information

Obtaining Knowledge. Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology.

Obtaining Knowledge. Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology. Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology 1.Obtaining Knowledge 1. Correlation 2. Causation 2.Hypothesis Generation & Measures 3.Looking into

More information

Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms

Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation

More information

GAFCHROMIC DOSIMETRY MEDIA TYPE MD-V3

GAFCHROMIC DOSIMETRY MEDIA TYPE MD-V3 GAFCHROMIC DOSIMETRY MEDIA TYPE MD-V3 WARNING: Store below 25ºC Store away from radiation sources Do not expose film to sunlight Handle film carefully, creasing may cause damage Do not expose to temperatures

More information

ASCO Initiatives in Personalized Medicine. Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology

ASCO Initiatives in Personalized Medicine. Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology ASCO Initiatives in Personalized Medicine Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology Financial Disclosures No financial relationships to disclose.

More information

Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer

Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer Ryan J. Burri; Nancy Y. Lee Published: 03/23/2009 Abstract and Introduction Abstract Head and neck cancer is best managed in a multidisciplinary

More information

Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda

Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda Stomach (Gastric) Cancer Prof. M K Mahajan ACDT & RC Bathinda Gastric Cancer Role of Radiation Layers of the Stomach Mucosa Submucosa Muscularis Serosa Stomach and Regional Lymph Nodes Stomach and Regional

More information

QA of intensity-modulated beams using dynamic MLC log files

QA of intensity-modulated beams using dynamic MLC log files 36 Original Article QA of intensity-modulated beams using dynamic MLC log files M. Dinesh Kumar, N. Thirumavalavan, D. Venugopal Krishna, M. Babaiah Department of Radiation Oncology, Yashoda Cancer Institute,

More information

Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology

Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate Professor Radiation Oncology Disclosure Information I have no financial relationships to disclose relevant to the conten of this presentation.

More information

Peptide receptor radionuclide treatment of neuroendocrine tumours

Peptide receptor radionuclide treatment of neuroendocrine tumours Peptide receptor radionuclide treatment of neuroendocrine tumours Jann Mortensen Dept. of Clinical Physiology, Nuclear Medicine & PET Neuroendocrine Tumor Center of Excellence Rigshospitalet University

More information

PET/CT in Breast Cancer

PET/CT in Breast Cancer PET/CT in Breast Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria Overview Introduction Locorregional

More information

Prostate IMRT: Promises and Problems Chandra Burman, Ph.D. Memorial Sloan-Kettering Cancer Center, New York, NY 10021

Prostate IMRT: Promises and Problems Chandra Burman, Ph.D. Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Prostate IMRT: Promises and Problems Chandra Burman, Ph.D. Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Introduction Prostate is one of the treatment sites that is well suited for IMRT. For

More information

Endpoint Selection in Phase II Oncology trials

Endpoint Selection in Phase II Oncology trials Endpoint Selection in Phase II Oncology trials Anastasia Ivanova Department of Biostatistics UNC at Chapel Hill [email protected] Primary endpoints in Phase II trials Recently looked at journal articles

More information

Advanced Radiation Therapy of Cancer by Proton Beam

Advanced Radiation Therapy of Cancer by Proton Beam March 20th, 2014 Advanced Radiation Therapy of Cancer by Proton Beam Fukui Prefectural Hospital Proton Therapy Center Yamamoto, Kazutaka Wave (electromagnetic wave) IR (Ionizing) Radiation 700 400 350~100

More information

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,

More information

IBA Proton Therapy. Biomed days 2015. Vincent Bossier. System Architect [email protected]. Protect, Enhance and Save Lives

IBA Proton Therapy. Biomed days 2015. Vincent Bossier. System Architect Vincent.bossier@iba-group.com. Protect, Enhance and Save Lives Vincent Bossier System Architect [email protected] IBA Proton Therapy Biomed days 2015 Protect, Enhance and Save Lives 1 Agenda AN INTRODUCTION TO IBA WHY PROTON THERAPY CLINICAL WORKFLOW TREATMENT

More information

MINIMALLY INVASIVE THERMAL THERAPY FOR CANCER TREATMENT BY USING THIN COAXIAL ANTENNAS

MINIMALLY INVASIVE THERMAL THERAPY FOR CANCER TREATMENT BY USING THIN COAXIAL ANTENNAS MINIMALLY INVASIVE THERMAL THERAPY FOR CANCER TREATMENT BY USING THIN COAXIAL ANTENNAS K. Ito 1, K. Saito 1, T. Taniguchi 2, S. Okabe 2, and H. Yoshimura 1 1 Faculty of Engineering, Chiba University, Chiba,

More information

Dosimetry on the Intraoperative Procedure

Dosimetry on the Intraoperative Procedure LDR-Brachytherapy of Prostate Cancer: Impact of Post-Implant Dosimetry on the Intraoperative Procedure Dr. med. Armin Thöni Dr. phil. nat. Hans Neuenschwander PD Dr. med. Jörn Wulf Radio-Onkologie, Lindenhofspital

More information

THE ANSI/IEEE RF SAFETY STANDARD AND ITS RATIONALE. Om P. Gandhi and Gianluca Lazzi Department of Electrical Engineering Salt Lake City, Utah 84112

THE ANSI/IEEE RF SAFETY STANDARD AND ITS RATIONALE. Om P. Gandhi and Gianluca Lazzi Department of Electrical Engineering Salt Lake City, Utah 84112 Introduction THE ANSI/IEEE RF SAFETY STANDARD AND ITS RATIONALE Om P. Gandhi and Gianluca Lazzi Department of Electrical Engineering Salt Lake City, Utah 84112 In 1960, the American Standards Association

More information

Cell Phone Radiation Effects on Cancer. Tyler Barkich Central Catholic High School Grade 11

Cell Phone Radiation Effects on Cancer. Tyler Barkich Central Catholic High School Grade 11 Cell Phone Radiation Effects on Cancer Tyler Barkich Central Catholic High School Grade 11 Cancer Overview Cancer cells are cells that grow and divide at an irregular, unregulated pace. Apoptosis does

More information

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including

More information

1. In the general symbol cleus, which of the three letters. 2. What is the mass number of an alpha particle?

1. In the general symbol cleus, which of the three letters. 2. What is the mass number of an alpha particle? 1. In the general symbol cleus, which of the three letters Z A X for a nu represents the atomic number? 2. What is the mass number of an alpha particle? 3. What is the mass number of a beta particle? 4.

More information

Next Generation Small Animal PET Technology

Next Generation Small Animal PET Technology G4 PET/X-ray P R O D U C T N O T E Pre-clinical in vivo Imaging Key Benefits: High performance, ultra-sensitive PET technology designed for pre-clinical imaging 3D PET and X-ray whole body images Purpose

More information

MEDICAL DOSIMETRY. COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: therapy.

MEDICAL DOSIMETRY. COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: therapy. Graduate Catalog 2012-2013 Medical Dosimetry / 339 MEDICAL DOSIMETRY COLLEGE OF APPLIED SCIENCES AND ARTS Graduate Faculty: Collins, Kevin Scott, Associate Professor, Ph.D., Jensen, Steve, Emeritus Professor,

More information

Functional MRI for tumor delineation in prostate radiation therapy

Functional MRI for tumor delineation in prostate radiation therapy REVIEW For reprint orders, please contact: [email protected] Functional MRI for tumor delineation in prostate radiation therapy A unique property of radiation therapy is the capacity for a differential

More information